Company news
Epsilon Healthcare Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Quarterly Activities/Appendix 4C Cash Flow Report
October 29, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
October 29, 2026
Shareholder Update
September 27, 2026
Update to Appendix 4C Managing Director Loan
September 24, 2026
Change of Director's Interest Notice - Zoe Hutchings
September 17, 2026
Epsilon Progresses Global Manufacturing Opportunity
September 14, 2026
Change of Director's Interest Notice - Alan Beasley
September 10, 2026
Half Yearly Report and Accounts
August 31, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
July 29, 2026
Preliminary Final Report
February 27, 2026
Epsilon Pharma signs manufacturing agreement with Puro NZ
February 5, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 28, 2026
Reinstatement to Quotation
December 18, 2025
Pre-reinstatement Disclosure
December 18, 2025
Strengthening working capital position
December 18, 2025
Half Yearly Report and Accounts
December 16, 2025
Long Term Suspended Entities
October 15, 2025
Suspension from Official Quotation - Annual Listing Fees
August 22, 2025
Strategic $6.7m Sale and Leaseback of Southport Property
July 29, 2025
Extraordinary General Meeting - CEO & MD Update
June 27, 2025
CEO AGM Update
May 28, 2025
Epsilon Healthcare Issue of Loan Notes
May 15, 2025
Appendix 4E - 31 December 2023
February 28, 2025
Quarterly Appendix 4C Cash Flow Report
January 31, 2025
Quarterly Activities Report
January 31, 2025
Placement
December 19, 2024
Company Update
December 19, 2024
Letter to Shareholders
December 16, 2024
Appointment of Administrator
December 18, 2023
Suspension from Quotation
December 18, 2023
Pause in Trading
December 18, 2023
Receipt of section 249D Notice
December 1, 2023
Response to ASX Appendix 4C Query
November 22, 2023
Termination of Chief Executive Officer
November 21, 2023
Notice of Extraordinary General Meeting/Proxy Form
November 21, 2023
Chief Executive Officer Appointment
May 19, 2023
Medicinal Cannabis Permit Renewed
May 12, 2023
Q3 2022 Quarterly Update and Appendix 4C
October 31, 2022
Capital Raising
September 1, 2022
Half Year Accounts & Appendix 4D
August 31, 2022
Trading Halt
August 31, 2022
Q2 2022 Quarterly Update and Appendix 4C
July 28, 2022
Executive Leadership Changes
July 21, 2022
Valens Exclusive Partnership Update
July 4, 2022
Q1 2022 Quarterly Update and Appendix 4C
May 1, 2022
Epsilon Secures Capital Raising
May 1, 2022
Appendix 4G and CGS
March 31, 2022
Mid Quarter Update
March 11, 2022
Epsilon Commences Partnership with The Valens Company
March 3, 2022
Appendix 4E
February 28, 2022
Decks
- Investor Presentation (November 2020)
Investor deck · 23 slides · Nov 2, 2020
- Investor Presentation (June 2020)
Investor deck · 14 slides · Jun 12, 2020
- Investor Presentation (September 2019)
Investor deck · 18 slides · Sep 24, 2019